See today's BioWorld Science
To read the full story, subscribe or sign in.
Immuno-oncology

Kelun-Biotech′s ADC SKB-518 cleared to enter clinic in US

April 25, 2025
Sichuan Kelun-Biotech Biopharmaceutical Co. Ltd. has been granted IND clearance by the FDA for its antibody-drug conjugate (ADC) drug SKB-518.
BioWorld Science Regulatory Cancer Antibody-drug conjugate Immuno-oncology FDA IND